Search research articles
Contact Us
Filters
Showing results (41-50 of 85) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1997
Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agent
E K Rowinsky, G S Long, D A Noe, et al.
Journal of the National Cancer Institute
|
June 5, 1996
Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines
S H Kaufmann, D Peereboom, C A Buckwalter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1997
Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation
T L Chen, M J Kennedy, L W Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1996
Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy
L W Anderson, T L Chen, O M Colvin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1996
Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy
M A Carducci, R A Abrams, C J Yeo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumors
S O'Reilly, L B Grochow, R C Donehower, et al.
Cancer Research
|
February 15, 1995
Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation
T L Chen, J L Passos-Coelho, D A Noe, et al.
Cancer Research
|
January 15, 1994
Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks
E K Rowinsky, L B Grochow, D S Ettinger, et al.
Journal of the National Cancer Institute
|
December 7, 1988
Clinical and pharmacologic reappraisal of dichloromethotrexate
A Hantel, E K Rowinsky, D A Noe, et al.
Cancer Treatment Reports
|
January 1, 1987
High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial
S M Longnecker, R C Donehower, A E Cates, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 85) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1997
Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agent
E K Rowinsky, G S Long, D A Noe, et al.
Journal of the National Cancer Institute
|
June 5, 1996
Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines
S H Kaufmann, D Peereboom, C A Buckwalter, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1997
Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation
T L Chen, M J Kennedy, L W Anderson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 1996
Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy
L W Anderson, T L Chen, O M Colvin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 1, 1996
Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy
M A Carducci, R A Abrams, C J Yeo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumors
S O'Reilly, L B Grochow, R C Donehower, et al.
Cancer Research
|
February 15, 1995
Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation
T L Chen, J L Passos-Coelho, D A Noe, et al.
Cancer Research
|
January 15, 1994
Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks
E K Rowinsky, L B Grochow, D S Ettinger, et al.
Journal of the National Cancer Institute
|
December 7, 1988
Clinical and pharmacologic reappraisal of dichloromethotrexate
A Hantel, E K Rowinsky, D A Noe, et al.
Cancer Treatment Reports
|
January 1, 1987
High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial
S M Longnecker, R C Donehower, A E Cates, et al.
Page
of 9